What to expect when Congress takes on EpiPen maker Mylan

September 21, 2016 3:08 PM

24 0

Lawmakers will get their chance to vent their fury at the executive who oversaw the EpiPen price hike, Mylan CEO Heather Bresch, at a congressional hearing this afternoon.

The emergency allergy injection has become the latest target of the public's simmering frustration about rising prescription drug prices. Today's hearing by the House Committee on Oversight and Government Reform will provide an outlet -- and a stage -- for politicians' exasperation.

Read more

To category page